Company research / TXG
10x Genomics, Inc. (TXG)
- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
For the year ended 2025-12-31, 10x Genomics, Inc. reported revenue of $642.82M. Revenue grew 5.2% from the prior annual period.
Key ratios (year ended 2025-12-31)
69.1%
Gross margin
-9.5%
Operating margin
-6.8%
Net margin
-5.5%
Return on year-end equity
5.2%
Revenue growth (YoY)
Beyond the statements
Follow the company.
Explore new filings, reported insider transactions and company relationships.